Bharat Parenterals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
For the full year, sales was INR 2,179.8 million compared to INR 2,120.1 million a year ago. Revenue was INR 2,297.2 million compared to INR 2,197.9 million a year ago. Net income was INR 164.4 million compared to INR 210.5 million a year ago. Basic earnings per share from continuing operations was INR 28.4 compared to INR 36.67 a year ago. Diluted earnings per share from continuing operations was INR 28.4 compared to INR 36.67 a year ago.